Present-day workflows used for determining the MOA of novel compounds frequently contain an array of practical screening assays incorporating a myriad of isolated biological targets. These methods commonly will not file functionality in the dynamic ecosystem where these targets usually reside. This is especially essential for ion channel targets https://proleviate.com/